These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


199 related items for PubMed ID: 4944035

  • 21. Teratogen update: penicillamine.
    Rosa FW.
    Teratology; 1986 Feb; 33(1):127-31. PubMed ID: 3738805
    [No Abstract] [Full Text] [Related]

  • 22. The copper-controlled diet: current aspects of dietary copper restriction in management of copper metabolism disorders.
    Smithgall JM.
    J Am Diet Assoc; 1985 May; 85(5):609-10. PubMed ID: 3886765
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Penicillamine for scleroderma.
    Fulghum DD, Katz R.
    Arch Dermatol; 1968 Jul; 98(1):51-2. PubMed ID: 5241672
    [No Abstract] [Full Text] [Related]

  • 25. Penicillamine-induced skin lesions. A possible example of human lathyrism.
    Katz R.
    Arch Dermatol; 1967 Feb; 95(2):196-8. PubMed ID: 4225251
    [No Abstract] [Full Text] [Related]

  • 26. [Liver copper determination in long-term treatment of Wilson's disease with D-penicillamine].
    Lange J, Brandt G.
    Med Welt; 1981 Jan 16; 32(3):109-10. PubMed ID: 7207132
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Late presentation of Wilson's disease].
    Santander Vaquero C.
    Rev Esp Enferm Dig; 2002 Aug 16; 94(8):502-3. PubMed ID: 12486857
    [No Abstract] [Full Text] [Related]

  • 29. Zinc treatment for symptomatic Wilson disease: moving forward by looking back.
    Schilsky M.
    Hepatology; 2009 Nov 16; 50(5):1341-3. PubMed ID: 19877301
    [No Abstract] [Full Text] [Related]

  • 30. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
    Ping CC, Hassan Y, Aziz NA, Ghazali R, Awaisu A.
    J Clin Pharm Ther; 2007 Feb 16; 32(1):101-7. PubMed ID: 17286794
    [Abstract] [Full Text] [Related]

  • 31. [Ultrastructural comparative study of the behavior of collagen tissue and elastic tissue during 3 pathological states (Marfans disease, scleroderma due to vitamin K-1 lathyrogenic effect of penicillamine)].
    Gauthier Y, Surlève-Bazeille JE, Gauthier O, Texier L.
    Ann Dermatol Syphiligr (Paris); 1973 Feb 16; 100(5-6):525-9. PubMed ID: 4802994
    [No Abstract] [Full Text] [Related]

  • 32. Penicillamine.
    Med Lett Drugs Ther; 1967 Jun 30; 9(13):51-2. PubMed ID: 6035365
    [No Abstract] [Full Text] [Related]

  • 33. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine].
    D'Addabbo A, Damato VD, Germinario L, Campanella G, Boccuni N.
    Acta Neurol (Napoli); 1971 Jun 30; 26(4):436-48. PubMed ID: 5132825
    [No Abstract] [Full Text] [Related]

  • 34. [Biochemical bases and therapeutic possibilities of K. Wilson's hepatolenticular degeneration].
    Grau-Veciana JM, Barraquer-Bordas L.
    Arch Neurobiol (Madr); 1967 Jun 30; 30(3):251-74. PubMed ID: 4970136
    [No Abstract] [Full Text] [Related]

  • 35. [Penicillamine in the treatment of patients with systemic scleroderma].
    Gandzha IM.
    Vrach Delo; 1987 May 30; (5):66-7. PubMed ID: 3617690
    [No Abstract] [Full Text] [Related]

  • 36. [Anatomo-clinical study of a case of Wilson's disease treated with chelating agents for 5 years].
    Boudin G, Pépin B, Milhaud M, Jérome H, Pacilly A.
    Rev Neurol (Paris); 1968 Jan 30; 118(1):27-35. PubMed ID: 5697565
    [No Abstract] [Full Text] [Related]

  • 37. [Penicillamine treatment of Wilson's disease].
    Falkmer S, Samuelson G, Sjölin S.
    Lakartidningen; 1969 May 14; 66(20):2097-105. PubMed ID: 5795695
    [No Abstract] [Full Text] [Related]

  • 38. Withdrawal of penicillamine from zinc sulphate-penicillamine maintenance therapy in Wilson's disease: promising, safe and cheap.
    Sinha S, Taly AB.
    J Neurol Sci; 2008 Jan 15; 264(1-2):129-32. PubMed ID: 17765927
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.